21st October 2026, Wednesday

Latest Posts

HealthTech News

  • AI model detects signs of faulty DNA repair in ovarian cancer using tissue images
    on October 21, 2026 at 9:00 pm

    An AI model created by researchers at King’s can detect signs of faulty repair mechanisms in ovarian cancer cells, potentially leading to a low-cost, widely accessible diagnostic tool in the future. By analyzing tissue images, the model could accurately recognize tumors that contained broken DNA repair mechanisms. This could enable clinicians to choose treatments that exploit this flaw. The findings are published in Nature Communications.

  • First generic combo hormone patch could make menopause relief more affordable
    on October 21, 2026 at 9:00 pm

    Women looking for relief from menopause symptoms could soon have a more affordable option for a weekly hormone patch.

  • Half-matched bone marrow transplant expands options for children with severe aplastic anemia
    on October 21, 2026 at 8:40 pm

    Researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins Children’s Center report that bone marrow transplant using half-matched family donors achieved a 96% survival rate among child, adolescent and young adult patients with severe aplastic anemia, a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells. The approach expands access to potentially curative treatment for patients who do not have a fully matched donor.

  • Three-week radiation course a safe option for breast cancer patients undergoing reconstruction, trial shows
    on October 21, 2026 at 8:40 pm

    Results of a national clinical trial led by the Alliance for Clinical Trials in Oncology in conjunction with NRG Oncology and the Canadian Cancer Trials Group show that a shorter, three-week radiation schedule following a mastectomy is as safe and effective as the standard five-week treatment for women undergoing breast reconstruction. The results of the RT CHARM trial (Alliance A221505) are published in the Journal of Clinical Oncology.

  • How trustworthy is AI breast cancer detection? New method gauges uncertainty for individual patients
    on October 21, 2026 at 8:20 pm

    While AI offers the ability to improve human experts’ ability to diagnose and treat diseases like breast cancer, well-publicized errors across the broader AI field are cause for concern. A team from the University of Pittsburgh has used PSC’s flagship Bridges-2 supercomputer to design a deep neural network (DNN) that takes uncertainty into account in diagnosing breast scan images.